4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-22-046973
Director bought 46,170 shares at an average $108.28 ($4,999,230)
From the SEC's structured data for this filing
Trades in this filing
Chambers Michael Andrew · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-08-19 | Purchase : show line 1 in the form | +40,110 | $108.20 | $4,339,902 | 45,018 | D |
| 2022-08-19 | Purchase : show line 2 in the form | +6,060 | $108.80 | $659,328 | 51,078 | D |
| Open-market purchases · 46,170 sh · avg $108.28 · $4,999,230 | ||||||
Loading xslF345X03/doc4.xml…